In agreement with the current work, the pro-inflammatory cytokines TNF-α and IL-1β, known to induce cellular senescence [83], were reduced in the groups that received MT-treated MSCs, with the lowest levels in the AD-MSC group. The gene discussed is IL1B; the disease is Alzheimer disease.